Using a tilt table to evaluate syncope

American Journal of the Medical Sciences

Volumn 317, Issue 2, 1999, Pages 110-116

  Kapoor, Wishwa N ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Neurally mediated syncope; Neurocardiogenic syncope; Tilt testing

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; ISOPRENALINE;

BRADYCARDIA; CONFERENCE PAPER; DIAGNOSTIC VALUE; HYPOTENSION; PATHOPHYSIOLOGY; REPRODUCIBILITY; SYNCOPE; TILT TABLE TEST;

EID: 0032737680     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199902000-00005     Document Type: Conference Paper

References (70)

1. Kapoor WN, Karpf M, Maher Y, et al. Syncope of unknown origin: the need for a more cost-effective approach to its diagnostic evaluation. JAMA 1982;247:2687-91.
2. Kapoor W. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-75.
3. Benditt DG, Remole S, Bailin S, et al. Tilt table testing for evaluations of neurally-mediated (cardioneurogenic) syncope: rational and proposed protocols. Pacing Clin Electrophysiol 1991;14:1528-37.
4. Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993; 15:1117-20.
5. Mark AL. The Bezold-Jarisch reflex revisited. Clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;1:90-102.
6. Abboud FM. Ventricular syncope. N Engl J Med 1989;320: 390-2.
7. Fitzpatrick AP, Banner N, Cheng A, et al. Vasovagal syncope may occur after orthotopic heart transplantation. J Am Coll Cardiol 1993;21:1132-7.
8. Lightfoot JT, Rowe SA, Fortney SM. Occurrence of presyncope in subjects without ventricular innervation. Clin Sci (Colch) 1993;85:695-700.
9. Waxman MB, Cameron DA, Wald RW. Role of ventricular vagal afferents in the vasovagal reactions. J Am Coll Cardiol. 1993;21:1138.
10. Morita H, Vatner SF. Effects of hemorrhage on renal nerve activity in conscious dogs. Circ Res 1985;57:788-93.
11. Abe H, Kobayasi H, Nakashima Y, et al. Plasma catecholamines and cyclic AMP response during head-up tilt test in patients with neurocardiogenic (vasodepressor) syncope. Pacing Clin Electrophysiol 1995;18:1419-26.
12. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res 1965;9:189-94.
13. Sander-Jensen K, Mehlsen J, Secher NH, et al. Progressive central hypovolemia in man resulting in vasovagal syncope? Haemodynamic and endocrine variables during venous torniquets of the thighs. Clin Physiol 1987;7:231-42.
14. Oparil S, Vassaux C, Sanders CA, et al. Role of renin in acute postural homeostasis. Circulation 1970;41:89-95.
15. Zanchetti AS. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation 1977;56:691-8.
16. Wang BC, Sundet WD, Hakumakaki MOK, et al. Vasopressin and renin responses to hemorrhage in conscious, cardiac-denervated dogs. Am J Physiol 1983;245:H399-H405.
17. Bie P, Secher NH, Astrup A, et al. Cardiovascular and endocrine responses to head-up tilt and vasopressin infusion in humans. Am J Physiol 1986;251:R735-41.
18. Grubb BP, Kosinski DJ. Serotonin and syncope: an emerging connection? Eur J Cardiac Pacing Electrophysiol 1995;5: 306.
19. Grubb B, Samoil D, Kosinski D, et al. The use of serotonin reuptake for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing. Pacing Clin Electrophysiol 1994;17:1434-6.
20. Rubin PC, McLean K, Reid JL. Endogenous opioids and baroreflex control in humans. Hypertension 1983;5:535-8.
21. Schadt JC, Hasser EM. Interaction of vasopressin and opioids during rapid hemorrhage in conscious rabbits. Am J Physiol 1991;260:R373-81.
22. Kaufmann H, Berman J, Oribe E, et al. Possible increase in EDRF/NO in neurally mediated syncope (abstract). Clin Auton Res 1993;3:69.
23. Engel GL. Psychologic stress, vasodepressor (vasovagal) syncope, and sudden death. Ann Intern Med 1978;89:403-12.
24. Sledge WH. Antecedent psychological factors in the onset of vasovagal syncope. Psychosom Med 1978;40:568-579.
25. Kapoor W, Karpf M, Wieand S, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
26. Eagle KA, Black HR. The impact of diagnostic tests in evaluating patients with syncope. Yale J Biol Med 1983;56: 1-8.
27. Silverstein MD, Singer DE, Mulley A, et al. Patients with syncope admitted to medical intensive care units. JAMA 1982;248:1185-9.
28. Martin GJ, Adams SL, Martin GH, et al. Prospective evaluation of syncope. Ann Emerg Med 1984;13:499-504.
29. Day SC, Cook EF, Funkenstein H, et al. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;73:15-23.
30. Kapoor WN, Smith M, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88.
31. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996;28:263-75.
32. Grubb BP, Gerard G, Rousch K, et al. Differentiation of convulsive syncope and epilepsy with head up tilt table testing. Ann Intern Med 1991;115:871-6.
33. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51.
34. Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head up tilt testing. Ann Intern Med 1991;114:1013-9.
35. Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76:267-72.
36. Grubb BP, Kosinski D. Current trends in the etiology, diagnosis and management of neurocardiogenic syncope. Curr Opin Cardiol 1996;11:32-41.
37. Calkins H, Kadish A, Sousa J, Rosenheck S, Morady F. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol 1991;67:207-9.
38. Waxman MB, Yao L, Cameron DA, Wald RW, Roseman J. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989;63:58-65.
39. Kapoor WN, Brant NL. Evaluation of syncope by upright tilt testing with isoproterenol: a nonspecific test. Ann Intern Med 1992;116:358-63.
40. Natale A, Akhtar M, Jazayeri M, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995;92:54-8.
41. Brooks R, Ruskin JN, Powell AC, et al. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993;71:1289-92.
42. Benditt DG, Lurie KG, Adler SW, et al. Rationale and methodology of head-up tilt table testing for evaluation of neurally mediated (cardioneurogenic) syncope. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. Philadelphia: WB Saunders; 1995. p. 1115-28.
43. van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal response. Clin Sci (Colch) 1991;81:575-86.
44. Blanc JJ, Mansourati J, Maheu B, et al. Reproducibility of a positive passive upright tilt test at seven-day interval in patients with syncope. Am J Cardiol 1993;72:469-71.
45. Morillo CA, Leitch JW, Yee R, et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-8.
46. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995;25:65-69.
47. Sheldon R, Splawinski J, Killam S. Reproducibility of upright tilt-table tests in patients with syncope. Am J Cardiol 1992;69:1300-5.
48. Grubb BP, Wolfe W, Temesy-Armos P, et al. Reproducibility of head upright tilt table test results in patients with syncope. Pacing Clin Electrophysiol 1992;15:1477-81.
49. Sutton R. Vasovagal syncope: to tilt or not to tilt? In: Raviele A, editor. Cardiac arrhythmias 1997: Proceedings of the 5th International Workshop on Cardiac Arrhythmias; 1997 Oct 7-10; Venice, Italy. New York: Springer-Verlag, p. 389-92.
50. Kenny RA, Bayliss J, Ingram A, et al. Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986;1(8494):1352-5.
51. Fitzpatrick A, Theodorakis G, Varda P, et al. The incidence of malignant vasovagal syncope in patients with recurrent syncope. Eur Heart J 1991;12:389-94.
52. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, et al. The usefulness of head-up tilt testing and hemodynamic investigations in the work up of syncope of unknown origin. Pacing Clin Electrophysiol 1988;11:1202-14.
53. Strasberg B, Rechavia E, Sagie A, et al. The head-up tilt table test in patients with syncope of unknown origin. Am Heart J 1989;118:923-7.
54. Sheldon R, Rose S, Koshman ML. Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests. Am J Cardiol 1997;80:581-5.
55. Oribe E, Caro S, Perera R, et al. Syncope:, the diagnostic value of head-up tilt testing. Pacing Clin Electrophysiol 1997;20:874-9.
56. Cox MM, Perlman BA, Mayor MR, et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-8.
57. Freeman R. Midodrine and other pressor drugs. In Robertson D, Low PA, Polinsky RJ, editors. Primer on the autonomic nervous system. Boston: Academic Press; 1996.
58. Grubb BP, Samoil D, Kosinski D, et al. The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-4.
59. Grubb BP, Wolfe DA, Samoil D, et al. Usefulness of fluoxetine hydrochloride in the treatment of resistant upright tilt-induced syncope. Pacing Clin Electrophysiol 1993;16:458-64.
60. Jaeger FJ, Fouad-Tarazi FM, Abi-Samra FM, et al. Transdermal scopolamine for treatment of vasovagal syncope (abstract). Clin Res 1987;35:822.
61. Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension bradycardia. Am J Cardiol 1990;65:1339-44.
62. Nelson S, Stanley M, Love C, et al. Autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 1991;151:2425-9.
63. Scott WA, Giacomo P, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995;76:400-2.
64. Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-9.
65. Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac packing with drug therapy in the treatment of neurocardiogenic syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-90.
66. Fitzpatrick AP, Ahmed R, Sutton R. A randomized trial of medical therapy in "malignant vasovagal syndrome" or "neurally-mediated bradycardia/hypotension syndrome" Eur J Cardiac Pacing Electrophysiol 1991;2:99-102.
67. Brignole M, Menozzi C, Gianfranchi L, et al. A Controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70: 339-42.
68. Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-81.
69. Benditt DG, Petersen M, Lurie K, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 1995;122:204-9.
70. Oh JH, Kapoor WK. Psychiatric illness and syncope. Cardiol Clin 1997;15:269-75.